Clinical Practice Guideline for the secondary prevention of stroke. Update



This CPG addresses pharmacological treatment for the secondary prevention of ischaemic and haemorrhagic stroke in adults with atrial fibrillation, patent foramen ovale (PFO) or heart valve diseases, in both primary care and hospital settings.

The target population for this guideline is patients diagnosed with stroke or transient ischaemic attack (TIA) who are candidates for secondary prevention aimed at delaying or reducing the likelihood of stroke recurrence.

This version in English contains the following types of information:

  • Clinical questions
  • Recommendations
  • Rationale
  • Complete clinical question (link to the version in Spanish)
  • References.

To access the full version of the CPG (as a multilayer presentation or PDF), the methods employed, material for patients, families and other caregivers, and other information in Spanish please click on the following link: